Close to one lakh children below the age of five years died of diarrhoea attributable to rotavirus infection in India in 2008, accounting for 22 per cent of the total deaths reported globally that year, the latest edition of the Lancet Infectious Diseases magazine has reported. Worldwide in 2008, diarrhoea related to rotavirus infection resulted in 4,53,000 deaths in children younger than 5 years — 37 per cent of deaths attributable...
More »SEARCH RESULT
India leads in rotavirus infection deaths: Lancet by Aarti Dhar
Close to one lakh children below the age of five years died of diarrhoea attributable to rotavirus infection in 2008, accounting for 22 per cent of the total deaths reported globally, reports the latest edition of the Lancet Infection Diseases magazine. Diarrhoea related with the rotavirus infection resulted in 453,000 deaths worldwide in 2008 among children younger than five years—37 per cent of deaths attributable to diarrhoea with five countries accounting...
More »Medicines: For Saving Life or For Superprofits? by Bharat Dogra
Will patent rights be used only for ensuring the legitimate interests of Pharmaceutical Companies, or will these be used in an exaggerated and unjust way to deprive patients of their right to life? This crucial question, which has been debated time and again in the context of the significant case of Glivec, an anti-cancer drug, has now reached a critical stage. It may be pointed out here that as early as...
More »Bitter pill for Big Pharma by Bhupesh Bhandari
A committee headed by Planning Commission member Arun Maira, the former head of The Boston Consulting Group in India, wants all acquisitions of Indian Pharmaceutical Companies by foreigners to be scanned by the Competition Commission of India or CCI. The report will now be sent to Prime Minister Manmohan Singh and Planning Commission Deputy Chairman Montek Singh Ahluwalia. Prime Minister Singh is expected to take a final view on the...
More »Affordable medicine
-The Business Standard It appears a committee headed by Planning Commission member Arun Maira examining the case for continued unrestricted foreign direct investment (FDI) in the pharmaceutical industry has opted to oppose the move to change the present regime. The only concession it is willing to make to the health and commerce ministries’ demand that approval of such investment be routed through the Foreign Investment Promotion Board is to ask for...
More »